Back
Freeport-McMoRan Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
FCX
Freeport-McMoRan
Last Price:
$45.81
Seasonality Move:
0.51%
Sell
43
SRPT
Sarepta Therapeutics
Last Price:
$18.22
Seasonality Move:
20.21%
Buy
68
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $45.77. The Score for FCX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $18.20. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $45.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $18.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.35 | Buy |
Relative Strength Index (14 RSI): | 69.34 | Buy |
Chaikin Money Flow: | 4399445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.87 - 43.27) | Buy |
Bollinger Bands (100): | (35.17 - 41.41) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.63 | Sell |
Relative Strength Index (14 RSI): | 22.9 | Sell |
Chaikin Money Flow: | 2644712 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.11 - 39.13) | Sell |
Bollinger Bands (100): | (31.38 - 92.06) | Sell |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.26 | Buy |
20-day SMA: | 42.12 | Buy |
50-day SMA: | 39.62 | Buy |
200-day SMA: | 40.82 | Buy |
8-day EMA: | 43.58 | Buy |
20-day EMA: | 42.16 | Buy |
50-day EMA: | 40.29 | Buy |
200-day EMA: | 40.36 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.83 | Buy |
20-day SMA: | 26.89 | Sell |
50-day SMA: | 38.26 | Sell |
200-day SMA: | 91.97 | Sell |
8-day EMA: | 18.98 | Sell |
20-day EMA: | 24.85 | Sell |
50-day EMA: | 37.93 | Sell |
200-day EMA: | 79.67 | Sell |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.54 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.88 per share, and an increase next year of $5.33 per share.
Freeport-McMoRan Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |